Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.32 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.32 |
| ▸ | TGM2 | P21980 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4116527 | 0.86 | DPP8 (0.33) | DPP8DPP9 | |
| SCHEMBL13994978 | 0.85 | TGM2 (0.34) | TGM2 | |
| SCHEMBL13866174 | 0.82 | DPP4 (0.33) | TGM2 | |
| SCHEMBL15182749 | 0.81 | — | — | |
| SCHEMBL5144548 | 0.79 | TSHR (0.36) | TGM2 | |
| SCHEMBL4863633 | 0.79 | TGM2 (0.31) | TGM2 | |
| SCHEMBL14210237 | 0.78 | CYP17A1 (0.34) | DPP8DPP9 | |
| SCHEMBL15182750 | 0.78 | — | — | |
| SCHEMBL14446201 | 0.78 | PKM (0.34) | DPP8DPP9TGM2 | |
| SCHEMBL3686165 | 0.78 | PKM (0.34) | DPP8DPP9TGM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090156854-A1 | ADAMANTANE DERIVATIVES AND PROCESS FOR PRODUCING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2009-06-18 | — | — | US | disclosed |
| US-7528279-B2 | Adamantane derivatives and process for producing the same | IDEMITSU KOSAN CO., LTD. (JP) | 2009-05-05 | — | — | US | disclosed |
| US-20070129532-A1 | Adamantane derivatives and process for producing the same | IDEMITSU KOSAN CO., LTD (JP) | 2007-06-07 | — | — | US | disclosed |
| EP-1712542-A1 | ADAMANTANE DERIVATIVES AND PROCESS FOR PRODUCING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2006-10-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090156854-A1 | ADAMANTANE DERIVATIVES AND PROCESS FOR PRODUCING THE SAME | ADH1A, ADH5, TAS1R2 | DPP8 2184/4885DPP9 1134/4885TGM2 998/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.